4//SEC Filing
Cooper Simon Peter 4
Accession 0001209191-21-050890
CIK 0001664710other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:56 PM ET
Size
5.7 KB
Accession
0001209191-21-050890
Insider Transaction Report
Form 4
Cooper Simon Peter
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-08-10+60,000→ 60,000 totalExercise: $34.98Exp: 2031-08-09→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest twenty-five percent (25%) on August 2, 2022, and six and one-quarter percent (6.25%) of such shares shall vest at the end of each successive three (3) month period thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001877225
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:56 PM ET
- Size
- 5.7 KB